XML 43 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Plans and Stock-based Compensation (Tables)
3 Months Ended
Apr. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations:

Three Months Ended
April 30,
20252024
(in thousands)
Cost of revenue$1,223 $1,084 
Research and development8,614 8,303 
Sales and marketing3,079 5,441 
General and administrative4,947 6,771 
Total stock-based compensation expense$17,863 $21,599 
Schedule of Activity of Restricted Stock Units and Performance Restricted Stock Units
A summary of RSUs outstanding under the 2021 EIP as of April 30, 2025 and changes during the fiscal year-to-date period then ended is presented in the following table:
 Number of SharesWeighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 202536,617,081 $2.86 
RSU granted941,525 $0.60 
RSU vested(3,473,798)$3.74 
RSU forfeited(996,562)$3.30 
Outstanding as of April 30, 202533,088,246 $2.69 
A summary of PRSUs outstanding under the 2021 EIP as of April 30, 2025 and changes during the fiscal year-to-date period then ended is presented in the following table:
 Number of SharesWeighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 20253,733,180 $2.39 
PSU vested— — 
Outstanding as of April 30, 20253,733,180 $2.39 
Schedule of Stock Option Activity
A summary of options outstanding under the 2017 Plan and 2007 Plan as of April 30, 2025 and changes during the fiscal year-to-date period then ended is presented in the following table:
 Number of Stock Option AwardsWeighted Average Exercise PriceWeighted Average Remaining Contractual term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 20252,705,924 $0.77 3.9$528 
Options exercised(61,871)$0.64 
Options cancelled(131,798)$0.74 
Outstanding as of April 30, 20252,512,255 $0.77 3.8$17 
Options vested and expected to vest as of April 30, 20252,512,255 $0.77 3.8$17 
Exercisable as of April 30, 20252,512,255 $0.77 3.8$17